Examination of Various Endogenous glucose-related hormones and glycemic variability in patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
Not Applicable
Recruiting
- Conditions
- End stage renal disease Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000045582
- Lead Sponsor
- Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have taken oral hypoglycemic agents, insulin preparations, or GLP-1 receptor agonists within the past 7 days at the time of obtaining consent Long hemodialysis time, more than 4 hours Patients with allergies to wheat, butter, maltose, chicken eggs, soybeans, peaches, apples, walnuts, peanuts (which may be included in the manufacturing ingredients) and Mealtest S Patients with markedly impaired swallowing function Patients using a pacemaker
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method